Painter Scott D, Ovsyannikova Inna G, Poland Gregory A
Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN 55905, USA.
Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN 55905, USA; Division of General Internal Medicine, USA.
Vaccine. 2015 Aug 26;33(36):4422-9. doi: 10.1016/j.vaccine.2015.06.101. Epub 2015 Jul 8.
Despite the high success of protection against several infectious diseases through effective vaccines, some sub-populations have been observed to respond poorly to vaccines, putting them at increased risk for vaccine-preventable diseases. In particular, the limited data concerning the effect of obesity on vaccine immunogenicity and efficacy suggests that obesity is a factor that increases the likelihood of a poor vaccine-induced immune response. Obesity occurs through the deposition of excess lipids into adipose tissue through the production of adipocytes, and is defined as a body-mass index (BMI) ≥ 30 kg/m(2). The immune system is adversely affected by obesity, and these "immune consequences" raise concern for the lack of vaccine-induced immunity in the obese patient requiring discussion of how this sub-population might be better protected.
尽管通过有效的疫苗在预防多种传染病方面取得了巨大成功,但仍观察到一些亚人群对疫苗反应不佳,这使他们患疫苗可预防疾病的风险增加。特别是,关于肥胖对疫苗免疫原性和效力影响的有限数据表明,肥胖是增加疫苗诱导免疫反应不良可能性的一个因素。肥胖是通过脂肪细胞的产生将多余的脂质沉积到脂肪组织中而发生的,其定义为体重指数(BMI)≥30 kg/m²。肥胖会对免疫系统产生不利影响,这些“免疫后果”引发了人们对肥胖患者缺乏疫苗诱导免疫力的担忧,需要讨论如何更好地保护这一亚人群。